Literature DB >> 22144443

Evaluation of an IgY-based immunomagnetic enzyme-linked immunosorbent assay system for detection of circulating Schistosoma japonicum antigen in serum samples from patients in China.

Jia-hui Lei1, Bing-tao Su, Hong Xu, Ji-long Shen, Xiao-hong Guan, Zhen-qing Feng, Yong-long Li, Ming-xing Xu, Wen-qi Liu.   

Abstract

We have developed a novel egg yolk antibody (IgY)-coated magnetic beads antigen-capture immunoassay for detection of a circulating antigen of Schistosoma japonicum in serum samples of patients in schistosomiasis-endemic areas of China. This IgY-based immunomagnetic bead enzyme-linked immunosorbent assay (IgY-IMB-ELISA) uses polyclonal IgY-coated magnetic beads as a capture antibody, and a monoclonal IgG as a detection antibody. The sensitivity of the magnetic immunoassay was 100% (40 of 40) in cases of acute infection and 91.5% (107 of 117) in chronic cases of schistosomiasis, and no positive reaction was found in 0 of 49 healthy persons. Cross-reactivity was 3.3% (1 of 33) with clonorchiasis and 0% (0 of 20) with paragonimiasis. There was a significant correlation between ELISA absorbance value and egg count (eggs per gram feces) and a correlation coefficient of 0.88 in a small sample of 14 patients. The results demonstrated that the IgY-IMB-ELISA is a sensitive and specific assay for detection of human schistosomiasis japonica.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144443      PMCID: PMC3225151          DOI: 10.4269/ajtmh.2011.11-0051

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  42 in total

1.  Chicken IgY: utilizing the evolutionary difference.

Authors:  A Larsson; J Sjöquist
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1990       Impact factor: 2.268

2.  Immunomagnetic beads assay for the detection of botulinum neurotoxin types C and D.

Authors:  Frank Gessler; Katrin Hampe; Michaela Schmidt; Helge Böhnel
Journal:  Diagn Microbiol Infect Dis       Date:  2006-07-11       Impact factor: 2.803

3.  Drug discovery: schistosome treatment.

Authors:  Sadaf Shadan
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

Review 4.  Chicken antibodies: a clinical chemistry perspective.

Authors:  D Carlander; J Stålberg; A Larsson
Journal:  Ups J Med Sci       Date:  1999       Impact factor: 2.384

Review 5.  Schistosomiasis: from risk assessment to control.

Authors:  Nils Robert Bergquist
Journal:  Trends Parasitol       Date:  2002-07

6.  Circulating schistosomal antigen in diagnosis and assessment of cure in individuals infected with Schistosoma mansoni.

Authors:  M M Hassan; M A Badawi; M Strand
Journal:  Am J Trop Med Hyg       Date:  1992-06       Impact factor: 2.345

7.  Mass spectrometric detection of urinary oligosaccharides as markers of Schistosoma mansoni infection.

Authors:  Marjolein L M Robijn; Joost Planken; Dieuwke Kornelis; Cornelis H Hokke; André M Deelder
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-11-09       Impact factor: 2.184

8.  Circulating anodic antigen (CAA) levels in different age groups in a Zimbabwean rural community endemic for Schistosoma haematobium determined using the magnetic beads antigen-capture enzyme-linked immunoassay.

Authors:  P Ndhlovu; H Cadman; S Gundersen; B J Vennervald; H Friis; N O Christensen; G Mutasa; K Kaondera; G Mandaza; A M Deelder
Journal:  Am J Trop Med Hyg       Date:  1996-05       Impact factor: 2.345

9.  The global epidemiological situation of schistosomiasis and new approaches to control and research.

Authors:  D Engels; L Chitsulo; A Montresor; L Savioli
Journal:  Acta Trop       Date:  2002-05       Impact factor: 3.112

Review 10.  IgY: a promising antibody for use in immunodiagnostic and in immunotherapy.

Authors:  Wilmar Dias da Silva; Denise V Tambourgi
Journal:  Vet Immunol Immunopathol       Date:  2010-01-07       Impact factor: 2.046

View more
  7 in total

1.  Specific humoral response of hosts with variable schistosomiasis susceptibility.

Authors:  Patrick Driguez; Hamish E G McWilliam; Soraya Gaze; David Piedrafita; Mark S Pearson; Rie Nakajima; Mary Duke; Angela Trieu; Denise L Doolan; Fernanda C Cardoso; Algis Jasinskas; Geoffrey N Gobert; Philip L Felgner; Alex Loukas; Els Meeusen; Donald P McManus
Journal:  Immunol Cell Biol       Date:  2015-06-05       Impact factor: 5.126

2.  Chicken IgY-based coproantigen capture ELISA for diagnosis of human opisthorchiasis.

Authors:  Salma Teimoori; Yuji Arimatsu; Thewarach Laha; Sasithorn Kaewkes; Piya Sereerak; Manop Sripa; Sirikachorn Tangkawattana; Paul J Brindley; Banchob Sripa
Journal:  Parasitol Int       Date:  2016-04-29       Impact factor: 2.230

3.  Immunodiagnosis of opisthorchiasis using parasite cathepsin F.

Authors:  Salma Teimoori; Yuji Arimatsu; Thewarach Laha; Sasithorn Kaewkes; Piya Sereerak; Sirikachorn Tangkawattana; Paul J Brindley; Banchob Sripa
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

4.  Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients.

Authors:  Yan Lu; Bin Xu; Chuan Ju; Xiaojin Mo; Shenbo Chen; Zheng Feng; Xiaoning Wang; Wei Hu
Journal:  Parasit Vectors       Date:  2012-06-11       Impact factor: 3.876

5.  Detection of Clonorchis sinensis circulating antigen in sera from Chinese patients by immunomagnetic bead ELISA based on IgY.

Authors:  Ge Nie; Ting Wang; Shengjun Lu; Wenqi Liu; Yonglong Li; Jiahui Lei
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

6.  New approaches with different types of circulating cathodic antigen for the diagnosis of patients with low Schistosoma mansoni load.

Authors:  Rafaella Grenfell; Donald A Harn; Smanla Tundup; Akram Da'dara; Liliane Siqueira; Paulo Marcos Zech Coelho
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

7.  Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements.

Authors:  Tatjana Damm; Holger Spiegel; Stefan Barth; Rainer Fischer; Joerg Naehring
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.